Bristol-Myers Squibb (BMY)
Sector: | Health Care |
Super Investor Stats: | |
Ownership count: | 8 |
Ownership rank: | 39 |
% of all portfolios: | 0.251% |
Hold Price * : | $56.56 |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
3 |
$310,151 |
Sells |
1 |
$38,930 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
≡ |
Kahn Brothers Group |
8.48 |
Reduce 16.45% |
690,252 |
39,041,000 |
≡ |
Hillman Value Fund |
3.04 |
Reduce 29.42% |
108,700 |
6,148,000 |
≡ |
Bill Miller - Miller Value Partners |
2.61 |
Add 35.00% |
108,000 |
6,108,000 |
≡ |
Harry Burn - Sound Shore |
2.56 |
Buy |
1,373,687 |
77,696,000 |
≡ |
Richard Pzena - Hancock Classic Value |
2.50 |
Reduce 46.07% |
330,566 |
18,697,000 |
≡ |
Dodge & Cox |
0.59 |
Reduce 0.10% |
11,344,039 |
641,619,000 |
≡ |
David Katz - Matrix Asset Advisors |
0.03 |
Reduce 3.03% |
5,449 |
308,000 |
≡ |
Jensen Investment Management |
0.01 |
|
26,375 |
1,492,000 |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
21 Feb 2025 |
BOERNER CHRISTOPHER S. |
Chief Executive Officer |
20 Feb 2025 |
2,000 |
55.05 |
110,096 |
19 Feb 2025 |
HIRAWAT SAMIT |
EVP,Chief Med.Offr.,Drug Dev. |
14 Feb 2025 |
1,823 |
54.84 |
100,000 |
05 Nov 2024 |
HIRAWAT SAMIT |
EVP,Chief Med.Offr.,Drug Dev. |
01 Nov 2024 |
1,830 |
54.68 |
100,055 |
07 Dec 2023 |
BOERNER CHRISTOPHER S. |
Chief Executive Officer |
05 Dec 2023 |
2,000 |
49.78 |
99,560 |
30 Nov 2023 |
BOERNER CHRISTOPHER S. |
Chief Executive Officer |
28 Nov 2023 |
3,071 |
48.86 |
150,049 |
21 Nov 2023 |
SAMUELS THEODORE R. II |
Director |
20 Nov 2023 |
8,500 |
49.81 |
423,385 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock